FDA Approved: ALVAIZ — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for ALVAIZ (eltrombopag).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Immune Thrombocytopenia

Drugs mentioned

• ALVAIZ (eltrombopag)

Snippet

SUPPL AP for ALVAIZ (ELTROMBOPAG)